Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2006 | 1 |
2008 | 3 |
2009 | 2 |
2010 | 1 |
2023 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Effects of complementary eurythmy therapy on heart rate variability.
Complement Ther Med. 2009 Jun;17(3):161-7. doi: 10.1016/j.ctim.2008.09.005. Epub 2008 Nov 20.
Complement Ther Med. 2009.
PMID: 19398070
Clinical Trial.
Gene expression profiling in AGS cells stimulated with Helicobacter pylori isogenic strains (cagA positive or cagA negative).
Bach S, Makristathis A, Rotter M, Hirschl AM.
Bach S, et al.
Infect Immun. 2002 Feb;70(2):988-92. doi: 10.1128/IAI.70.2.988-992.2002.
Infect Immun. 2002.
PMID: 11796637
Free PMC article.
Item in Clipboard
Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients with slow virologic response.
Ferenci P, Laferl H, Scherzer TM, Maieron A, Hofer H, Stauber R, Gschwantler M, Brunner H, Wenisch C, Bischof M, Strasser M, Datz C, Vogel W, Löschenberger K, Steindl-Munda P; Austrian Hepatitis Study Group.
Ferenci P, et al.
Gastroenterology. 2010 Feb;138(2):503-12, 512.e1. doi: 10.1053/j.gastro.2009.10.058. Epub 2009 Nov 10.
Gastroenterology. 2010.
PMID: 19909752
Clinical Trial.
Item in Clipboard
Liver cyst of echinococcus granulosus with rupture into the biliary tree--successful endoscopic and pharmaceutical treatment.
Dzirlo L, Wasilewski M, Poeschl E, Hellmich B, Bach S, Hoffmann E, Kerstan E.
Dzirlo L, et al. Among authors: bach s.
Am J Gastroenterol. 2006 Jul;101(7):1674-5. doi: 10.1111/j.1572-0241.2006.00627_5.x.
Am J Gastroenterol. 2006.
PMID: 16863580
No abstract available.
Item in Clipboard
Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response.
Ferenci P, Laferl H, Scherzer TM, Gschwantler M, Maieron A, Brunner H, Stauber R, Bischof M, Bauer B, Datz C, Löschenberger K, Formann E, Staufer K, Steindl-Munda P; Austrian Hepatitis Study Group.
Ferenci P, et al.
Gastroenterology. 2008 Aug;135(2):451-8. doi: 10.1053/j.gastro.2008.04.015. Epub 2008 May 27.
Gastroenterology. 2008.
PMID: 18503773
Clinical Trial.
Item in Clipboard
A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3.
Ferenci P, Brunner H, Laferl H, Scherzer TM, Maieron A, Strasser M, Fischer G, Hofer H, Bischof M, Stauber R, Gschwantler M, Steindl-Munda P, Staufer K, Löschenberger K; Austrian Hepatitis Study Group.
Ferenci P, et al.
Hepatology. 2008 Jun;47(6):1816-23. doi: 10.1002/hep.22262.
Hepatology. 2008.
PMID: 18454510
Clinical Trial.
Item in Clipboard
Cite
Cite